0.23
-0.0071(-3.05%)
Currency In USD
| Previous Close | 0.23 |
| Open | 0.23 |
| Day High | 0.24 |
| Day Low | 0.22 |
| 52-Week High | 1.3 |
| 52-Week Low | 0.22 |
| Volume | 243,732 |
| Average Volume | 399,919 |
| Market Cap | 5.42M |
| PE | -0.38 |
| EPS | -0.6 |
| Moving Average 50 Days | 0.29 |
| Moving Average 200 Days | 0.43 |
| Change | -0.01 |
If you invested $1000 in Adial Pharmaceuticals, Inc. (ADIL) since IPO date, it would be worth $2.23 as of January 14, 2026 at a share price of $0.226. Whereas If you bought $1000 worth of Adial Pharmaceuticals, Inc. (ADIL) shares 5 years ago, it would be worth $4.39 as of January 14, 2026 at a share price of $0.226.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
GlobeNewswire Inc.
Nov 26, 2025 1:00 PM GMT
GLEN ALLEN, Va., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and r
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire Inc.
Nov 14, 2025 1:30 PM GMT
GLEN ALLEN, Va., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and r
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
GlobeNewswire Inc.
Oct 17, 2025 1:00 PM GMT
GLEN ALLEN, Va., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and r